The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL): First results from CIBMTR.
 
Emily Tomasulo
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol Myers Squibb; Genentech; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Sanofi
 
Nitin Jain
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Adaptive Biotechnologies; ADC Therapeutics; ADC Therapeutics; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb/Celgene; CareDX; Cellectis; Ipsen; Janssen; MEI Pharma; MingSight; NovalGen; Pfizer; Pharmacyclics; Precision Biosciences; SERVIER; TG Therapeutics
Consulting or Advisory Role - Abbvie/Genentech; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb/Celgene; CareDX; Cellectis; Ipsen; Janssen; MEI Pharma; MingSight; NovalGen; Pharmacyclics; Precision Biosciences; SERVIER; TG Therapeutics
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); ADC Therapeutics (Inst); Aprea Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Carna Biosciences (Inst); Celgene (Inst); Cellectis (Inst); CRC Oncology (Inst); Dialectic Therapeutics (Inst); Fate Therapeutics (Inst); Genentech/Roche (Inst); KisoJi Biotechnology (Inst); Kite, a Gilead company (Inst); Loxo/Lilly (Inst); Medisix Therapeutics (Inst); Medisix Therapeutics (Inst); MingSight (Inst); Newave Pharmaceutical (Inst); NovalGen (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Precision Biosciences (Inst); Sana Biotechnology (Inst); SERVIER (Inst); Takeda (Inst); TransThera Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - CRLF2 Bispecific antibody
 
John Byrd
Stock and Other Ownership Interests - Eilean Pharma; Vincerx Pharma
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Eilean; Kartos Therapeutics; Newave Pharmaceutical; Ohio State Univ Drug Development Inst (Inst); Orange Grove Bio; Orbimed; Vincerx Pharma
Research Funding - Eilean Pharma (Inst); Newave Pharmaceutical (Inst); Orange Grove Bio (Inst); Orbimed
Patents, Royalties, Other Intellectual Property - OSU Patents
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Novartis; Pharmacyclics; TG Therapeutics
 
Travis Williams
Employment - St Lukes Medical Center Boise
Speakers' Bureau - Kite, a Gilead company
 
Monalisa Ghosh
Honoraria - Bristol-Myers Squibb/Celgene; Cabaletta Bio
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Novartis (Inst)
 
Iris Isufi
Consulting or Advisory Role - Celgene, BMS
 
Matthew Lunning
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Fate Therapeutics; Genentech; Genentech; Incyte; Ipsen; Kite, a Gilead company; Loxo; Pfizer; Recordati; VITTORIA
Research Funding - curis (Inst); FATE THERAPEUTICS
 
David Bernasconi
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Debasmita Roy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Samantha Jaglowski
Consulting or Advisory Role - Cardinal Health; crispr therapeutics
 
Tania Jain
Employment - Johns Hopkins University
Consulting or Advisory Role - Abbvie; Abbvie; Blueprint Medicines; Bristol Myers Squibb Foundation; Calytrix; Cogent Biosciences; Cogent Biosciences; Galapagos UK; In8Bio; Incyte; Incyte; Incyte; Karyopharm Therapeutics; Kite, a Gilead company; MorphoSys; Protagonist Therapeutics; Takeda; Telios; TScan Therapeutics
Research Funding - Incyte (Inst); Kartos Therapeutics (Inst); TScan Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor: Apparatus for combined localization and dosimetry in image guided radiation therapy of the head and neck (PCT/US2018/027717). No royalties.
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Bradley Hunter
Honoraria - AbbVie; Astellas Pharma; Bristol-Myers Squibb; Carobou Biosceinces; Genentech; Genmab; In8Bio; Johnson & Johnson; Kite, a Gilead Company; Kyverna Therapeutics (Inst); Novartis; Poseida Therapeutics; Regeneron
Consulting or Advisory Role - AbbVie; Astellas Pharma; Bristol-Myers Squibb; Carobou Biosciences; Genentech; Genmab; In8 Bio; Johnson & Johnson; Kite, a Gilead Company; Kyverna Therapeutics (Inst); Novartis; Poseida Therapeutics; Regeneron
Speakers' Bureau - Abbvie; Genmab; Kite, a Gilead Company
Research Funding - Johnson & Johnson (Inst)